Kx Advisors

Kx Advisors is a boutique healthcare strategy consulting firm that focuses on growth strategies for clients in the pharmaceutical, biotechnology, medical device, diagnostics, life sciences, digital health, health IT, and private equity sectors. The firm is headquartered in Washington, DC, with additional offices in Boston, MA, and London, UK, employing over 50 professionals. Founded over 40 years ago as part of Kaiser Associates, Kx Advisors became an independent entity in 2019. The firm is led by Dan O’Neill, the managing partner and chief executive. In September 2023, Kx Advisors was acquired by BGB Group, which enhances its capabilities in clinical expertise and medical strategy. The firm provides data-driven consulting aimed at driving clinical innovation and business growth, with key practice areas including pharma and biotech, medical devices, diagnostics, digital health, and private equity. Kx Advisors is known for its pragmatic solutions and strong cultural values.